Anti-tumor necrosis factor-α induction therapy for patients with active inflammatory bowel disease during pregnancy is effective and safe

被引：0
|
作者：
Macisaac, M. [1 ]
Rowe, S. [1 ]
Ross, A. [1 ]
Flanagan, E. [1 ]
Julsgaard, M. [3 ]
Bell, S. [2 ]
机构：
[1] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Monash Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[3] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
339
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [21] Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
    Cheon, Jae Hee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 769 - 777
  • [22] Pulmonary lesions in patients with inflammatory bowel disease - the baseline and under anti-tumor necrosis factor therapy
    Borisov, Sergey
    Frolova, Ksenia
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [23] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Alexis Calloway
    Robin Dalal
    Dawn B. Beaulieu
    Caroline Duley
    Kimberly Annis
    Lawrence Gaines
    Chris Slaughter
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2017, 62 : 3563 - 3567
  • [24] Malignancy Outcomes in Inflammatory Bowel Disease Patients on Immune Modulators and Anti-Tumor Necrosis Factor Therapy
    Patel, Umangi
    Lichtenstein, Gary
    Scott, Frank
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S484 - S484
  • [25] Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy
    Zanoli, Luca
    Inserra, Gaetano
    Cappello, Maria
    Ozturk, Kadir
    Castellino, Pietro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 981 - 982
  • [26] Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases
    Bujanover, Yoram
    Weiss, Batia
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (8-9): : 634 - 639
  • [27] Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window
    Papamichael, Konstantinos
    Vande Casteele, Niels
    Ferrante, Marc
    Gils, Ann
    Cheifetz, Adam S.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) : 1510 - 1515
  • [28] Anti-Tumor Necrosis Factor Treatment of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Jegadeesan, Ramprasad
    Kochhar, Gursimran
    Hayat, Umar
    Kim, Ahyoung J.
    Lan, Nan
    Sanaka, Madhusudhan R.
    Shen, Bo
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2016, 150 (04) : S396 - S397
  • [29] Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease
    William J. Sandborn
    Current Gastroenterology Reports, 2003, 5 (6) : 501 - 505
  • [30] Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
    Yunho, Jung
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (01): : 1 - 3
12345